Taltz Results In Spondyloarthritis Add To Lilly Franchise Hopes

 
• By Jo Shorthouse
  
Yacht
Seemingly plain sailing for ixelizumab in non-radiographic axial spondyloarthritis trial • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D